FIELD: chemistry.
SUBSTANCE: present invention relates to novel methods for synthesis of formula I compound (Iclaprim) which relates to dihydrofolate reductase inhibitors
,
as well as to intermediate compounds used in said methods.
EFFECT: design of novel efficient methods for synthesis of formula I compound (Iclaprim).
13 cl, 2 tbl, 30 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVE OF 1'-BROMO-2',3',4'-TRIMETOXYBENZO[5',6':4,5]-(AR, 1S)-1-ACETAMIDO-6,7-DIHYDROCYCLOHEPTA-[3,4-F]-1H-INDOLE AND ITS APPLICATION | 2016 |
|
RU2630303C1 |
| PYRAZOLOPYRIDINE DERIVATIVES AS TTX-S BLOCKERS | 2013 |
|
RU2652117C2 |
| PYRIMIDINE DERIVATIVES AS INHIBITORS OF PD1/PD-L1 ACTIVATION | 2018 |
|
RU2783211C2 |
| ARYLAMIDE DERIVATIVES AS TTX-S BLOCKERS | 2011 |
|
RU2535671C1 |
| THIENO[2,3-d]PYRIMIDINES AS ANTIMICROBIAL AGENTS | 2018 |
|
RU2803136C2 |
| PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR CANCER TREATMENT | 2013 |
|
RU2672916C2 |
| FLUORINE-CONTAINING TEVINOL AND ORVINOL DERIVATIVES AND METHODS OF THEIR OBTAINING (VERSIONS) | 2012 |
|
RU2506265C1 |
| 6-1H-IMIDAZOQUINAZOLINE AND CHOLINE DERIVATIVES /MAO INHIBITORS FOR TREATING DEPRESSION | 2008 |
|
RU2472508C2 |
| β-D-2ʹ-DEOXY-2ʹ-α-FLUORO-2ʹ-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR TREATMENT OF DISEASES CAUSED BY HCV | 2016 |
|
RU2764767C2 |
| PYRIDINO[1,2-A]PYRIMIDONE ANALOGUE USED AS AN MTOR/PI3K INHIBITOR | 2015 |
|
RU2658912C1 |
